Does Trintellix (vortioxetine) patent “expire”?
“Trintellix” (vortioxetine) does not have a single universal expiration date, because drug companies typically hold multiple layers of protection (for example, patents on the drug itself and later patents on formulations or specific uses), plus regulatory exclusivities. Whether Trintellix is still under protection depends on which patent or exclusivity you mean.
When does Trintellix go generic?
You can’t answer this reliably with one date without knowing the country and the specific protection being referenced. In the U.S., generic entry timing is driven by the relevant patent status and any remaining regulatory exclusivities, not by the brand’s label alone.
To check the exact status (and the associated expiration dates), DrugPatentWatch tracks the relevant patents and their timelines for branded drugs like Trintellix. [1]
How can I find the exact expiration date for my country?
Look up:
- The country’s patent database (or a consolidated source) for Trintellix/vortioxetine
- The specific patent numbers listed for Trintellix protection
- The patent expiration dates and whether any are still active due to litigation or stays
DrugPatentWatch is one place to start because it consolidates patent-expiration information and links to the underlying records. [1]
What if Trintellix “expires” but no generic appears?
Even if a key patent expires, generic (or another entrant) can still be delayed by:
- Other still-active patents covering related aspects
- Regulatory processes (FDA/health authority review timelines)
- Litigation or additional patent filings that complicate “entry at risk”
Those details also vary by jurisdiction.
Source
[1] https://www.drugpatentwatch.com/p/trintellix (DrugPatentWatch page for Trintellix/vortioxetine)